U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), And Segment Forecasts, 2025 - 2030

U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn’s Disease), And Segment Forecasts, 2025 - 2030


Electro-medical And Electrotherapeutic Apparatus Market Growth & Trends

The global electro-medical and electrotherapeutic apparatus market size is anticipated to reach USD 95.5 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to grow at a CAGR of 6.4% from 2025 to 2030. Key factors driving market growth include the increasing geriatric population, advancements in technology, rising awareness among patients about diagnostic and treatment options, and the growing prevalence of various chronic disorders. For instance, the International Agency for Research on Cancer reported approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths worldwide in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates the need for effective diagnostic and treatment solutions. Electro-medical and electrotherapeutic apparatus play a crucial role in addressing this need by offering efficient and advanced devices that support accurate diagnoses, monitor patient conditions, and deliver therapeutic treatments. These devices are essential in improving patient outcomes and managing chronic conditions more effectively. Advancements in technology is further expected to contribute to overall market growth. For instance, in April 2024, Soterix Medical Inc., a global leader in non-invasive brain stimulation and complementary monitoring technologies, announced the launch of the MxN-GO EEG. This innovative system combines High-Definition transcranial Electrical Stimulation (HD-tES) with EEG, featuring a unique untethered design.

Strategic initiatives by key market players, such as mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, research and development (R&D) efforts, and expansion, are essential in driving the growth of the market. For example, in July 2024, Philips, a global leader in health technology, announced a partnership with Star Imaging in Pune to establish a first-of-its-kind MRI Training School in India. This institution will offer internationally recognized training on MRI technologies across 17 sub-specialties.

Electro-Medical And Electrotherapeutic Apparatus Market Report Highlights
  • In 2024, the diagnostic segment dominated the product segment by capturing a share of 37.9%.
  • The therapeutic equipment segment is anticipated to grow at the fastest CAGR during the forecast period.
  • Cardiology segment held the largest market share in the application segment by capturing a revenue share of 26.9% in 2024.
  • The neurology segment is expected to grow at the fastest rate during the forecast period.
  • Among end use, hospitals held a majority share of the market of 46.5% in 2024.
  • The ambulatory surgical centers segment is expected to grow at the fastest rate over the forecast period.
  • North America dominated the market with a share of 47.0% in 2024.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Type Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Type and Technology Segment Snapshot
2.3. Application Segment Snapshot
2.4. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Emerging chronic diseases patients
3.2.1.2. Increasing number of new FDA injectable generics drugs approvals
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of injectable
3.3. SWOT Analysis, by Factor
3.4. Industry Analysis- Porter’s
3.5. Consumer Behavior Analysis
3.6. Target Disease Population
3.7. Regulatory Scenario
3.8. Reimbursement Scenario
3.9. Unmet Needs and Opportunity Analysis
Chapter 4. Type Business Analysis
4.1. U.S. IVD & LDT For Autoimmune Diseases Market: Type Movement Analysis
4.2. IVD
4.2.1. IVD Market, 2018 - 2030 (USD Million)
4.2.2. By Technology
4.2.2.1. Immunoassays
4.2.2.1.1. Immunoassays Market, 2018 - 2030 (USD Million)
4.2.2.2. Clinical Chemistry
4.2.2.2.1. Clinical Chemistry Market, 2018 - 2030 (USD Million)
4.2.2.3. Hematology
4.2.2.3.1. Hematology Market, 2018 - 2030 (USD Million)
4.2.2.4. Coagulation
4.2.2.4.1. Coagulation Market, 2018 - 2030 (USD Million)
4.2.2.5. Microbiology
4.2.2.5.1. Microbiology Market, 2018 - 2030 (USD Million)
4.2.2.6. Molecular Diagnostics
4.2.2.6.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
4.2.2.7. Others
4.2.2.7.1. Others Market, 2018 - 2030 (USD Million)
4.2.3. By Application
4.2.3.1. Addison’s Disease
4.2.3.1.1. Addison’s Disease Market, 2018 - 2030 (USD Million)
4.2.3.2. Ankylosing Spondylitis
4.2.3.2.1. Ankylosing Spondylitis Market, 2018 - 2030 (USD Million)
4.2.3.3. Alopecia Areata
4.2.3.3.1. Alopecia Areata Market, 2018 - 2030 (USD Million)
4.2.3.4. Rheumatoid Arthritis
4.2.3.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
4.2.3.5. Systemic Lupus Erythematosus
4.2.3.5.1. Systemic Lupus Erythematosus Market, 2018 - 2030 (USD Million)
4.2.3.6. Systemic Sclerosis
4.2.3.6.1. Systemic Sclerosis Market, 2018 - 2030 (USD Million)
4.2.3.7. Psoriasis
4.2.3.7.1. Psoriasis Market, 2018 - 2030 (USD Million)
4.2.3.8. Antiphospholipid Antibody Syndrome
4.2.3.8.1. Antiphospholipid Antibody Syndrome Market, 2018 - 2030 (USD Million)
4.2.3.9. Diabetes Type 1
4.2.3.9.1. Diabetes Type 1 Market, 2018 - 2030 (USD Million)
4.2.3.10. Crohn’s Disease
4.2.3.10.1. Crohn’s Disease Market, 2018 - 2030 (USD Million)
4.2.3.11. Ulcerative Colitis
4.2.3.11.1. Ulcerative Colitis Market, 2018 - 2030 (USD Million)
4.2.3.12. Narcolepsy
4.2.3.12.1. Narcolepsy Market, 2018 - 2030 (USD Million)
4.2.3.13. Multiple Sclerosis
4.2.3.13.1. Multiple Sclerosis Market, 2018 - 2030 (USD Million)
4.2.3.14. Uveitis
4.2.3.14.1. Uveitis Market, 2018 - 2030 (USD Million)
4.2.3.15. Others
4.2.3.15.1. Others Market, 2018 - 2030 (USD Million)
4.3. LDT
4.3.1. LDT Market, 2018 - 2030 (USD Million)
4.3.2. By Technology
4.3.2.1. Immunoassays
4.3.2.1.1. Immunoassays Market, 2018 - 2030 (USD Million)
4.3.2.2. Clinical Chemistry
4.3.2.2.1. Clinical Chemistry Market, 2018 - 2030 (USD Million)
4.3.2.3. Hematology
4.3.2.3.1. Hematology Market, 2018 - 2030 (USD Million)
4.3.2.4. Coagulation
4.3.2.4.1. Coagulation Market, 2018 - 2030 (USD Million)
4.3.2.5. Microbiology
4.3.2.5.1. Microbiology Market, 2018 - 2030 (USD Million)
4.3.2.6. Molecular Diagnostics
4.3.2.6.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
4.3.2.7. Others
4.3.2.7.1. Others Market, 2018 - 2030 (USD Million)
4.3.3. By Application
4.3.3.1. Addison’s Disease
4.3.3.1.1. Addison’s Disease Market, 2018 - 2030 (USD Million)
4.3.3.2. Ankylosing Spondylitis
4.3.3.2.1. Ankylosing Spondylitis Market, 2018 - 2030 (USD Million)
4.3.3.3. Alopecia Areata
4.3.3.3.1. Alopecia Areata Market, 2018 - 2030 (USD Million)
4.3.3.4. Rheumatoid Arthritis
4.3.3.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
4.3.3.5. Systemic Lupus Erythematosus
4.3.3.5.1. Systemic Lupus Erythematosus Market, 2018 - 2030 (USD Million)
4.3.3.6. Systemic Sclerosis
4.3.3.6.1. Systemic Sclerosis Market, 2018 - 2030 (USD Million)
4.3.3.7. Psoriasis
4.3.3.7.1. Psoriasis Market, 2018 - 2030 (USD Million)
4.3.3.8. Antiphospholipid Antibody Syndrome
4.3.3.8.1. Antiphospholipid Antibody Syndrome Market, 2018 - 2030 (USD Million)
4.3.3.9. Diabetes Type 1
4.3.3.9.1. Diabetes Type 1 Market, 2018 - 2030 (USD Million)
4.3.3.10. Crohn’s Disease
4.3.3.10.1. Crohn’s Disease Market, 2018 - 2030 (USD Million)
4.3.3.11. Ulcerative Colitis
4.3.3.11.1. Ulcerative Colitis Market, 2018 - 2030 (USD Million)
4.3.3.12. Narcolepsy
4.3.3.12.1. Narcolepsy Market, 2018 - 2030 (USD Million)
4.3.3.13. Multiple Sclerosis
4.3.3.13.1. Multiple Sclerosis Market, 2018 - 2030 (USD Million)
4.3.3.14. Uveitis
4.3.3.14.1. Uveitis Market, 2018 - 2030 (USD Million)
4.3.3.15. Others
4.3.3.15.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Technology Business Analysis
5.1. U.S. IVD & LDT For Autoimmune Diseases Market: Technology Movement Analysis
5.2. Immunoassays
5.2.1. Immunoassays Market, 2018 - 2030 (USD Million)
5.3. Clinical Chemistry
5.3.1. Clinical Chemistry Market, 2018 - 2030 (USD Million)
5.4. Hematology
5.4.1. Hematology Market, 2018 - 2030 (USD Million)
5.5. Coagulation
5.5.1. Coagulation Market, 2018 - 2030 (USD Million)
5.6. Microbiology
5.6.1. Microbiology Market, 2018 - 2030 (USD Million)
5.7. Molecular Diagnostics
5.7.1. Molecular Diagnostics Market, 2018 - 2030 (USD Million)
5.8. Others
5.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. U.S. IVD & LDT For Autoimmune Diseases Market: Application Movement Analysis
6.2. Addison’s Disease
6.2.1. Addison’s Disease Market, 2018 - 2030 (USD Million)
6.3. Ankylosing Spondylitis
6.3.1. Ankylosing Spondylitis Market, 2018 - 2030 (USD Million)
6.4. Alopecia Areata
6.4.1. Alopecia Areata Market, 2018 - 2030 (USD Million)
6.5. Rheumatoid Arthritis
6.5.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
6.6. Systemic Lupus Erythematosus
6.6.1. Systemic Lupus Erythematosus Market, 2018 - 2030 (USD Million)
6.7. Systemic Sclerosis
6.7.1. Systemic Sclerosis Market, 2018 - 2030 (USD Million)
6.8. Psoriasis
6.8.1. Psoriasis Market, 2018 - 2030 (USD Million)
6.9. Antiphospholipid Antibody Syndrome
6.9.1. Antiphospholipid Antibody Syndrome Market, 2018 - 2030 (USD Million)
6.10. Diabetes Type 1
6.10.1. Diabetes Type 1 Market, 2018 - 2030 (USD Million)
6.11. Crohn’s Disease
6.11.1. Crohn’s Disease Market, 2018 - 2030 (USD Million)
6.12. Ulcerative Colitis
6.12.1. Ulcerative Colitis Market, 2018 - 2030 (USD Million)
6.13. Narcolepsy
6.13.1. Narcolepsy Market, 2018 - 2030 (USD Million)
6.14. Multiple Sclerosis
6.14.1. Multiple Sclerosis Market, 2018 - 2030 (USD Million)
6.15. Uveitis
6.15.1. Uveitis Market, 2018 - 2030 (USD Million)
6.16. Others
6.16.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Company Categorization
7.2. Strategy Mapping
7.2.1. New Product Launch
7.2.2. Partnership & Collaboration
7.2.3. Merger and Acquisition
7.2.4. Others
7.3. Company Market Share Analysis, 2024
7.4. Company Profiles/Listing
7.4.1. Adaptive Biotechnologies Corporation
7.4.1.1. Overview
7.4.1.2. Financial Performance
7.4.1.3. Product Benchmarking
7.4.1.4. Strategic Initiatives
7.4.2. Agilent Technologies, Inc
7.4.2.1. Overview
7.4.2.2. Financial Performance
7.4.2.3. Product Benchmarking
7.4.2.4. Strategic Initiatives
7.4.3. Bio-Rad Laboratories, Inc.
7.4.3.1. Overview
7.4.3.2. Financial Performance
7.4.3.3. Product Benchmarking
7.4.3.4. Strategic Initiatives
7.4.4. bioMerieux, Inc.
7.4.4.1. Overview
7.4.4.2. Financial Performance
7.4.4.3. Product Benchmarking
7.4.4.4. Strategic Initiatives
7.4.5. Corgenix, Inc. (Sebia)
7.4.5.1. Overview
7.4.5.2. Financial Performance
7.4.5.3. Product Benchmarking
7.4.5.4. Strategic Initiatives
7.4.6. F. Hoffmann-La Roche Ltd.
7.4.6.1. Overview
7.4.6.2. Financial Performance
7.4.6.3. Product Benchmarking
7.4.6.4. Strategic Initiatives
7.4.7. Quest Diagnostics, Inc.
7.4.7.1. Overview
7.4.7.2. Financial Performance
7.4.7.3. Product Benchmarking
7.4.7.4. Strategic Initiatives
7.4.8. PerkinElmer, Inc
7.4.8.1. Overview
7.4.8.2. Financial Performance
7.4.8.3. Product Benchmarking
7.4.8.4. Strategic Initiatives
7.4.9. Abbott Laboratories
7.4.9.1. Overview
7.4.9.2. Financial Performance
7.4.9.3. Product Benchmarking
7.4.9.4. Strategic Initiatives
7.4.10. Thermo Fisher Scientific, Inc.
7.4.10.1. Overview
7.4.10.2. Financial Performance
7.4.10.3. Product Benchmarking
7.4.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings